Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T van Oosterom

Showing results (171-180 of 196) with videos related to

Pageof 20
Sort By:
Lancet (London, England)|November 14, 2001
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I studyA T van Oosterom, I Judson, J Verweij, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1984
Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patientsM A Cornbleet, R C Stuart-Harris, I E Smith, et al.
British Journal of Cancer|November 21, 1998
Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significanceR de Wit, L Collette, R Sylvester, et al.
Journal of the National Cancer Institute|February 3, 2000
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaP Therasse, S G Arbuck, E A Eisenhauer, et al.
Journal of Neurology|June 1, 1994
The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trialJ M van Gerven, A Hovestadt, J W Moll, et al.
Anti-Cancer Drugs|October 18, 2001
Search for metabolites of ecteinascidin 743, a novel, marine-derived, anti-cancer agent, in manR W Sparidans, H Rosing, M J Hillebrand, et al.
British Journal of Cancer|February 12, 1998
Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patientsM Bakker, J P Droz, A R Hanauske, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma GroupM Debiec-Rychter, H Dumez, I Judson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase I study of spiroplatinB C Tanis, J B Vermorken, W W ten Bokkel Huinink, et al.
Cancer Treatment Reviews|June 1, 1988
Carboplatin in combination therapy for ovarian cancerW W ten Bokkel Huinink, M E van der Burg, A T van Oosterom, et al.
Pageof 20

Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
Lancet (London, England)|November 14, 2001
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I studyA T van Oosterom, I Judson, J Verweij, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1984
Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patientsM A Cornbleet, R C Stuart-Harris, I E Smith, et al.
British Journal of Cancer|November 21, 1998
Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significanceR de Wit, L Collette, R Sylvester, et al.
Journal of the National Cancer Institute|February 3, 2000
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaP Therasse, S G Arbuck, E A Eisenhauer, et al.
Journal of Neurology|June 1, 1994
The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trialJ M van Gerven, A Hovestadt, J W Moll, et al.
Anti-Cancer Drugs|October 18, 2001
Search for metabolites of ecteinascidin 743, a novel, marine-derived, anti-cancer agent, in manR W Sparidans, H Rosing, M J Hillebrand, et al.
British Journal of Cancer|February 12, 1998
Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patientsM Bakker, J P Droz, A R Hanauske, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma GroupM Debiec-Rychter, H Dumez, I Judson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase I study of spiroplatinB C Tanis, J B Vermorken, W W ten Bokkel Huinink, et al.
Cancer Treatment Reviews|June 1, 1988
Carboplatin in combination therapy for ovarian cancerW W ten Bokkel Huinink, M E van der Burg, A T van Oosterom, et al.
Pageof 20